Breaking News

George Clinical Rebrands to Emerald Clinical Trials

The new company continues to focus on end-to-end services while ⁠advancing innovations that help evolve global clinical research practices.

Author Image

By: Charlie Sternberg

Associate Editor

George Clinical, a clinical research organization (CRO) operating worldwide, has rebranded to become Emerald Clinical Trials. Emerald Clinical Trials continues to focus on end-to-end services across all therapeutic areas designed to change lives⁠ while ⁠advancing innovations that help evolve global clinical research practices. With its track record in Oncology and Cardio-Renal-Metabolic (CRM) therapeutic areas, expertise in Asia Pacific, and global scientific leadership, Emerald Clinical Tria...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics